Drug Profile

IPDP 2015

Alternative Names: IPDP-2015

Latest Information Update: 17 Jan 2023

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Initiator Pharma
Class Antidepressants; Small molecules
Mechanism of Action Neurotransmitter uptake inhibitors; Vesicular monoamine transport protein inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

17 Jan 2023 Initiator Pharma has patents pending for IPDP 2015 compound and its use for the treatment of Depressive disorders in China and Japan
17 Jan 2023 Initiator Pharma has patent protection for IPDP 2015 compound and its use for the treatment of Depressive disorders in Europe and USA
16 Jan 2023 Preclinical trials in Depressive disorders in Denmark (PO) before January 2023 (Initiator Pharma pipeline, January 2023)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com